ID: ALA510275

Max Phase: Preclinical

Molecular Formula: C37H50N2O10

Molecular Weight: 682.81

Molecule Type: Small molecule

Representations

Synonyms (2): Methyllycaconitine | Methyllycanonitine
Synonyms from Alternative Forms(2):

Canonical SMILES:  CCN1C[C@]2(COC(=O)c3ccccc3N3C(=O)C[C@H](C)C3=O)CC[C@H](OC)[C@@]34[C@@H]5C[C@H]6[C@H](OC)[C@@H]5[C@](O)(C[C@@H]6OC)[C@](O)([C@@H](OC)[C@H]23)[C@@H]14

Standard InChI:  InChI=1S/C37H50N2O10/c1-7-38-17-34(18-49-32(42)20-10-8-9-11-23(20)39-26(40)14-19(2)31(39)41)13-12-25(46-4)36-22-15-21-24(45-3)16-35(43,27(22)28(21)47-5)37(44,33(36)38)30(48-6)29(34)36/h8-11,19,21-22,24-25,27-30,33,43-44H,7,12-18H2,1-6H3/t19-,21+,22+,24-,25-,27+,28-,29+,30-,33-,34-,35+,36-,37-/m0/s1

Standard InChI Key:  XLTANAWLDBYGFU-BVFBBISOSA-N

Molecule Features

Natural Product: Yes

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 682.81

Molecular Weight (Monoisotopic): 682.3465

AlogP: 2.04

#Rotatable Bonds: 9

Polar Surface Area: 144.30

Molecular Species: BASE

HBA: 11

HBD: 2

#RO5 Violations: 2

HBA (Lipinski): 12

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 12.20

CX Basic pKa: 9.66

CX LogP: 0.52

CX LogD: -1.73

Aromatic Rings: 1

Heavy Atoms: 49

QED Weighted: 0.29

Np Likeness Score: 2.64

References

1. Chen J, Norrholm S, Dwoskin LP, Crooks PA, Bai D..  (2003)  N,N-disubstituted piperazines: synthesis and affinities at alpha4beta2(*) and alpha7(*) neuronal nicotinic acetylcholine receptors.,  13  (1): [PMID:12467625] [10.1016/s0960-894x(02)00849-1]

2. Xu R, Dwoskin LP, Grinevich VP, Deaciuc G, Crooks PA..  (2001)  Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues.,  11  (9): [PMID:11354387] [10.1016/s0960-894x(01)00193-7]

3. Navarro HA, Zhong D, Abraham P, Xu H, Carroll FI..  (2000)  Synthesis and pharmacological characterization of [(125)I]iodomethyllycaconitine ([(125)I]iodo-MLA). A new ligand for the alpha(7) nicotinic acetylcholine receptor.,  43  (2): [PMID:10649969] [10.1021/jm990544f]

4. Almeida LE, Pereira EF, Camara AL, Maelicke A, Albuquerque EX..  (2004)  Sensitivity of neuronal nicotinic acetylcholine receptors to the opiate antagonists naltrexone and naloxone: receptor blockade and up-regulation.,  14  (8): [PMID:15050620] [10.1016/j.bmcl.2004.01.004]

5. Bergmeier SC, Lapinsky DJ, Free RB, McKay DB..  (1999)  Ring E analogs of methyllycaconitine (MLA) as novel nicotinic antagonists.,  9  (15): [PMID:10465558] [10.1016/s0960-894x(99)00378-9]

6. Ayers JT, Dwoskin LP, Deaciuc AG, Grinevich VP, Zhu J, Crooks PA..  (2002)  bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors.,  12  (21): [PMID:12372503] [10.1016/s0960-894x(02)00687-x]

7. Bergmeier SC, Ismail KA, Arason KM, McKay S, Bryant DL, McKay DB..  (2004)  Structure activity studies of ring E analogues of methyllycaconitine. Part 2: Synthesis of antagonists to the alpha3beta4* nicotinic acetylcholine receptors through modifications to the ester.,  14  (14): [PMID:15203153] [10.1016/j.bmcl.2004.05.001]

8. Hardick DJ, Blagbrough IS, Cooper G, Potter BV, Critchley T, Wonnacott S..  (1996)  Nudicauline and elatine as potent norditerpenoid ligands at rat neuronal alpha-bungarotoxin binding sites: importance of the 2-(methylsuccinimido)benzoyl moiety for neuronal nicotinic acetylcholine receptor binding.,  39  (24): [PMID:8941400] [10.1021/jm9604991]

9. Jensen AA, Frølund B, Liljefors T, Krogsgaard-Larsen P..  (2005)  Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.,  48  (15): [PMID:16033252] [10.1021/jm040219e]

10. Mazurov A, Klucik J, Miao L, Phillips TY, Seamans A, Schmitt JD, Hauser TA, Johnson RT, Miller C..  (2005)  2-(Arylmethyl)-3-substituted quinuclidines as selective alpha 7 nicotinic receptor ligands.,  15  (8): [PMID:15808471] [10.1016/j.bmcl.2005.02.045]

11. Baker SR, Boot J, Brunavs M, Dobson D, Green R, Hayhurst L, Keenan M, Wallace L..  (2005)  High affinity ligands for the alpha7 nicotinic receptor that show no cross-reactivity with the 5-HT3 receptor.,  15  (21): [PMID:16165358] [10.1016/j.bmcl.2005.07.070]

12. Ivy Carroll F, Ma W, Navarro HA, Abraham P, Wolckenhauer SA, Damaj MI, Martin BR..  (2007)  Synthesis, nicotinic acetylcholine receptor binding, antinociceptive and seizure properties of methyllycaconitine analogs.,  15  (2): [PMID:17098430] [10.1016/j.bmc.2006.10.061]

13. Jensen AA, Zlotos DP, Liljefors T..  (2007)  Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,  50  (19): [PMID:17722904] [10.1021/jm070574f]

14. Manners GD, Panter KE, Pelletier SW..  (1995)  Structure-activity relationships of norditerpenoid alkaloids occurring in toxic larkspur (Delphinium) species.,  58  (6): [PMID:7673930] [10.1021/np50120a007]

15. Jacyno JM, Harwood JS, Lin NH, Campbell JE, Sullivan JP, Holladay MW..  (1996)  Lycaconitine revisited: partial synthesis and neuronal nicotinic acetylcholine receptor affinities.,  59  (7): [PMID:8759171] [10.1021/np960352c]

16. Huang J, Orac CM, McKay S, McKay DB, Bergmeier SC..  (2008)  The synthesis of 5-substituted ring E analogs of methyllycaconitine via the Suzuki-Miyaura cross-coupling reaction.,  16  (7): [PMID:18272373] [10.1016/j.bmc.2008.01.050]

17. Manners GD, Panter KE, Pfister JA, Ralphs MH, James LF..  (1998)  The characterization and structure-activity evaluation of toxic norditerpenoid alkaloids from two Delphinium species.,  61  (9): [PMID:9748371] [10.1021/np980013e]

18. Turabekova MA, Rasulev BF, Dzhakhangirov FN, Leszczynska D, Leszczynski J..  (2010)  Aconitum and Delphinium alkaloids of curare-like activity. QSAR analysis and molecular docking of alkaloids into AChBP.,  45  (9): [PMID:20594622] [10.1016/j.ejmech.2010.05.042]

19. Cutler P, Slater R, Edmunds AJ, Maienfisch P, Hall RG, Earley FG, Pitterna T, Pal S, Paul VL, Goodchild J, Blacker M, Hagmann L, Crossthwaite AJ..  (2013)  Investigating the mode of action of sulfoxaflor: a fourth-generation neonicotinoid.,  69  (5): [PMID:23112103] [10.1002/ps.3413]

20. Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG..  (2013)  Derivatives of dibenzothiophene for positron emission tomography imaging of α7-nicotinic acetylcholine receptors.,  56  (19): [PMID:24050653] [10.1021/jm401184f]

Source

Source(1):

• Scientific Literature